Refractory Multiple Myeloma: 1473 Clinical Trials, Page 146 of 148

« First Page «…5 10 15 …144 145 146 147 148 »

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

Condition(s):Non Hodgkin Lymphoma; Richter Transformation; Multiple Myeloma; T-cell-prolymphocytic Leukemia; Acute Myeloid Leukemia; Acute Lymphocytic Leukemia; Myeodysplastic Syndrome; Myelodysplastic/Myeloproliferative Neoplasm; Myelofibrosis; Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma; Chronic Myelomonocytic Leukemia-2; Myelodysplastic Neoplasm in Blast PhaseLast Updated:March 29, 2023Recruiting

1452

Bortezomib in Patients With Chronic Graft Versus Host Disease

Condition(s):Graft Versus Host DiseaseLast Updated:May 28, 2020Completed

1453

Study of BiRd Regimen Combined With BCMA CAR T-cell Therapy in Newly Diagnosed Multiple Myeloma (MM) Patients

Condition(s):Multiple MyelomaLast Updated:October 25, 2021Recruiting

1454

Study Assessing Safety and Efficiency of the Lenalidomide and Dexamethasone Combination in Patients With Chronic Lymphatic Leukemia (CLL) Relapsing or Resistant to Treatment

Condition(s):Chronic Lymphatic LeukemiaLast Updated:April 4, 2014Completed

1455

Response to Chimeric Antigen Receptor (CAR)-T Cells Therapy in Patients With Hematologic Malignancies Depending on Tumor Characteristics

Condition(s):Hematologic DiseasesLast Updated:December 24, 2019Not yet recruiting

1456

Panobinostat Biological Correlates Study

Condition(s):Nodal Lymphoma; Lymphoma With Cutaneous Involvement; Lymphoma in Leukemic Phase; Marrow Involvement With Lymphoma; Multiple MyelomaLast Updated:May 6, 2022Completed

1457

Pomalidomide, Dexamethasone and Rituximab in Waldenstrom’s Macroglobulinemia

Condition(s):Waldenstrom’s MacroglobulinemiaLast Updated:July 25, 2016Terminated

1458

Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies

Condition(s):Hematologic NeoplasmsLast Updated:April 10, 2023Suspended

1459

A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors

Condition(s):Malignancy; Non-hodgkin Lymphoma; Multiple Myeloma; Breast Cancer; Ovarian Cancer; Soft Tissue Sarcoma; Head and Neck Cancer; DLBCL; Mantle Cell Lymphoma; Follicular Lymphoma; Pancreatic Cancer; CLL; Small Cell Lung Cancer; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast CancerLast Updated:August 26, 2022Recruiting

1460

Safety Study of Anti-Programmed Death-Ligand 1 in Hematologic Malignancy

Condition(s):Non-Hodgkin’s Lymphoma; Hodgkin Lymphoma; Multiple Myeloma; Chronic Myelogenous LeukemiaLast Updated:February 23, 2012Withdrawn

« First Page «…5 10 15 …144 145 146 147 148 »

Trial Bulletin .com

Clinical Trials by Category

Clinical Trials Alphabetically

About

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.